Developing a blood test for early detection of breast cancer, pancreatic cancer, and multiple myeloma
Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma
This study is working on a new blood test that can help find early signs of breast cancer, pancreatic cancer, and multiple myeloma, so patients can get diagnosed sooner and have better treatment options.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-10930880 on NIH RePORTER |
What this research studies
This research focuses on creating and validating a multi-analyte liquid biopsy technology that can detect early signs of breast cancer, pancreatic cancer, and multiple myeloma through blood samples. By analyzing various biomarkers released by tumors into the bloodstream, the study aims to improve early cancer assessment and diagnosis. The research will involve collaboration among clinical, research, and industry experts to ensure the technology is effective and ready for clinical use. Patients may benefit from more accurate and earlier detection of these cancers, potentially leading to better treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for or suspected of having breast cancer, pancreatic cancer, or multiple myeloma.
Not a fit: Patients with cancers not included in this research or those who are not at risk for the specified cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate detection of breast cancer, pancreatic cancer, and multiple myeloma, improving patient outcomes.
How similar studies have performed: Other research has shown promise in using liquid biopsy technologies for cancer detection, indicating that this approach has potential for success.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Kuhn, Peter — University of Southern California
- Study coordinator: Kuhn, Peter
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.